Department of Interventional Radiology, Shanghai Tongji Hospital, Tongji University School of Medicine, 389, Xincun Road, Shanghai, 200065, China.
Department of Neurology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Neuroradiology. 2019 Jul;61(7):833-842. doi: 10.1007/s00234-019-02205-0. Epub 2019 May 1.
This study aimed to report the clinical findings and initial clinical experience of endovascular recanalization for symptomatic subacute/chronic intracranial large artery occlusion (ILAO) of the anterior circulation.
From October 2015 to December 2017, 13 patients with symptomatic subacute/chronic ILAO of the anterior circulation were enrolled in this study and underwent endovascular recanalization. We collected the initial procedural results, including the rate of successful recanalization and periprocedural complications, and data pertaining to angiographic and clinical follow-up.
Recanalization was successful in 11 of 13 patients (84.6%). Intraoperative complications occurred in four cases, including symptomatic distal embolism in three cases; one of which was simultaneously complicated with artery dissection. Intracerebral hemorrhage occurred in one case. Eleven patients underwent angiographic follow-up, and 12 patients underwent clinical follow-up. The results of the angiography follow-up (mean 6 ± 3.29 months) showed that in-stent restenosis occurred in one of the 11 successfully recanalized patients. However, the artery was occluded again in the patient who achieved thrombolysis in cerebral infarction (TICI) grade of 2a after treatment. Clinical follow-up (mean 5.8 ± 2.25 months) showed no recurrence of transient ischemic attack (TIA) or stroke in ten successfully recanalized cases. However, the patient who developed in-stent stenosis suffered TIA.
Endovascular recanalization for symptomatic subacute/chronic ILAO of anterior circulation is feasible, relatively safe, and efficacious in highly selected cases, improving patients' symptoms in the short-term. However, further larger scale pilot studies are needed to determine the efficacy and long-term outcome associated with this treatment.
本研究旨在报告血管内再通治疗症状性急性/亚急性/慢性颅内前循环大血管闭塞(ILAO)的临床发现和初步临床经验。
2015 年 10 月至 2017 年 12 月,我们纳入了 13 例症状性急性/亚急性/慢性前循环 ILAO 患者并进行血管内再通治疗。我们收集了初始程序结果,包括再通成功率和围手术期并发症,并获得了血管造影和临床随访数据。
13 例患者中 11 例(84.6%)再通成功。4 例患者发生术中并发症,包括 3 例症状性远端栓塞,其中 1 例同时并发动脉夹层;1 例发生颅内出血。11 例患者接受血管造影随访,12 例患者接受临床随访。血管造影随访(平均 6±3.29 个月)结果显示,11 例再通成功的患者中有 1 例发生支架内再狭窄。然而,1 例经治疗后达到血栓溶解(TICI)2a 级的患者再次发生动脉闭塞。临床随访(平均 5.8±2.25 个月)显示,10 例再通成功的患者均无短暂性脑缺血发作(TIA)或中风复发。然而,发生支架内狭窄的患者发生了 TIA。
血管内再通治疗症状性急性/亚急性/慢性前循环 ILAO 是可行的,在高度选择的病例中相对安全且有效,可以在短期内改善患者的症状。然而,需要进一步进行更大规模的初步研究来确定这种治疗的疗效和长期结果。